Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 89.76%-276K | 0.49%-3.23M | -336.82%-1.04M | -241.67%-7M | 72.66%-1.5M | -127.75%-2.7M | -555.35%-3.24M | -64.11%440K | -46.37%4.94M | -201.12%-5.5M |
| Net profit before non-cash adjustment | 88.58%-1.38M | 29.79%-1.26M | 22.26%-1.96M | -167.75%-20.21M | -18.03%-3.8M | -985.27%-12.08M | -23.30%-1.8M | -44.12%-2.53M | 8.70%-7.55M | 24.94%-3.22M |
| Total adjustment of non-cash items | -102.67%-308K | 427.32%2.22M | -35.14%1.21M | 178.32%12.16M | -250.27%-1.65M | 1,210.47%11.52M | -67.52%421K | 70.04%1.87M | -41.88%4.37M | -68.00%1.1M |
| -Depreciation and amortization | -97.97%12K | -98.39%10K | -93.15%43K | -9.47%2.26M | -31.41%417K | -4.68%591K | -20.92%620K | 30.83%628K | -3.67%2.49M | 1.16%608K |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 1,042.36%8.45M | -319.62%-3.76M | ---- | ---- | ---- | -137.52%-897K | ---897K |
| -Disposal profit | -426.02%-1.28M | 1,217.68%2.21M | 259.08%1.17M | 435.91%1.6M | 91.47%1.08M | 242.03%392K | -1,900.00%-198K | --325K | --298K | --563K |
| -Net exchange gains and losses | --0 | --0 | --0 | -427.84%-1.59M | -101.10%-4K | -6,071.43%-1.67M | -1,172.73%-420K | 304.80%506K | 414.94%485K | 350.00%365K |
| -Other non-cash items | 133.33%3K | -100.72%-3K | -99.75%1K | -27.47%1.44M | 36.98%626K | -101.78%-9K | -21.54%419K | -17.24%408K | -26.07%1.99M | -21.07%457K |
| Changes in working capital | 166.10%1.41M | -124.28%-4.19M | -126.41%-290K | -87.16%1.04M | 216.98%3.95M | -121.47%-2.14M | -462.05%-1.87M | -41.60%1.1M | -18.51%8.12M | -153.48%-3.37M |
| -Change in receivables | -165.79%-1.86M | -890.83%-3.46M | -303.34%-1.77M | -74.39%3.91M | -12.88%568K | -83.53%2.82M | 92.38%-349K | -57.75%869K | 121.99%15.27M | -53.40%652K |
| -Change in inventory | --0 | --0 | --0 | -81.73%99K | --0 | 219.28%99K | 127.27%15K | -104.07%-15K | -3.04%542K | 242.66%311K |
| -Change in payables | 177.29%3.27M | 79.76%-727K | -35.89%1.48M | 113.41%1.65M | 180.06%7.17M | 40.53%-4.23M | -183.44%-3.59M | 521.98%2.3M | -587.03%-12.31M | -274.65%-8.96M |
| -Changes in other current assets | ---- | ---- | --0 | -200.00%-4.62M | -182.07%-3.79M | --1.23M | --0 | ---2.06M | --4.62M | --4.62M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | 0 | 0 | -11.11%8K | 0.00%8K | -5K | 3K | 100.00%2K | -18.18%9K | 260.00%8K | |
| Tax refund paid | 0 | 0 | 0 | -328.57%-30K | 25.00%-6K | -134.78%-8K | 38.46%-8K | 11.11%-8K | 95.81%-7K | -166.67%-8K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 89.81%-276K | 0.65%-3.23M | -340.09%-1.04M | -242.05%-7.03M | 72.70%-1.5M | -127.82%-2.71M | -539.57%-3.25M | -64.37%434K | -45.42%4.95M | -201.27%-5.5M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | --0 | --0 | --0 | -111.48%-7K | --0 | ---4K | --0 | ---3K | 1,625.00%61K | 1,750.00%66K |
| Net business purchase and sale | ---- | ---- | ---- | ---107K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment product transactions | 144.57%439K | 3,220.59%1.06M | 260.38%1.7M | 77.17%-2.76M | -323.36%-679K | 87.41%-985K | 99.26%-34K | ---1.06M | -705.47%-12.08M | 120.27%304K |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2K | ---- |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | --12K | --28K | ---- | ---- | ---- | --0 | --0 |
| Investing cash flow | 143.68%439K | 3,220.59%1.06M | 259.92%1.7M | 76.10%-2.87M | -306.99%-770K | 87.15%-1.01M | 99.26%-34K | ---1.06M | -699.14%-12.02M | 124.73%372K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 46.14%-3.88M | ---- |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Increase or decrease of lease financing | ---26K | --8K | ---42K | -316.67%-25K | ---25K | --0 | --0 | --0 | 60.00%-6K | --0 |
| Interest paid (cash flow from financing activities) | -113.33%-4K | 100.47%2K | 99.27%-3K | 26.95%-1.46M | -42.95%-659K | 105.89%30K | 19.31%-422K | 19.13%-410K | 26.25%-2M | 20.79%-461K |
| Financing cash flow | -200.00%-30K | 908.06%3.41M | 89.02%-45K | 74.73%-1.49M | 84.23%-684K | 105.89%30K | 19.62%-422K | 19.77%-410K | -275.54%-5.88M | 3.41%-4.34M |
| Net cash flow | ||||||||||
| Beginning cash position | -52.04%3.52M | -79.51%2.28M | -86.00%1.66M | -51.59%11.88M | -90.92%1.94M | -63.12%7.34M | -56.45%11.11M | -10.45%11.88M | 29.15%24.54M | -16.94%21.31M |
| Current changes in cash | 103.61%133K | 133.55%1.24M | 159.00%613K | 12.12%-11.38M | 68.77%-2.96M | -361.83%-3.68M | 33.87%-3.71M | -246.96%-1.04M | -316.19%-12.95M | -1,587.17%-9.47M |
| Effect of exchange rate changes | --0 | --0 | --0 | 296.60%1.17M | 8,284.38%2.68M | -14,408.33%-1.72M | -725.00%-66K | 3.10%266K | 164.90%294K | 105.73%32K |
| End cash Position | 88.64%3.65M | -52.04%3.52M | -79.51%2.28M | -86.00%1.66M | -86.00%1.66M | -90.92%1.94M | -63.12%7.34M | -56.45%11.11M | -51.59%11.88M | -51.59%11.88M |
| Free cash flow | 89.83%-276K | 0.65%-3.23M | -341.76%-1.04M | -242.34%-7.03M | 72.70%-1.5M | -127.86%-2.71M | -533.33%-3.25M | -64.61%431K | -45.45%4.94M | -201.34%-5.5M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.